XYLEK — Interwood Xylemboria ATENE Income Statement
0.000.00%
- €10.63m
- €36.86m
- €38.21m
- 33
- 78
- 38
- 46
Annual income statement for Interwood Xylemboria ATENE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 28 | 36.8 | 41 | 38.4 | 38.2 |
Cost of Revenue | |||||
Gross Profit | 6.33 | 10.6 | 11.1 | 8.72 | 9.09 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 33.8 | 32.4 | 36.8 | 35.8 | 36.5 |
Operating Profit | -5.76 | 4.34 | 4.19 | 2.63 | 1.67 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.13 | 3.02 | 2.74 | 0.545 | -0.475 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.65 | 2.84 | 2.02 | 0.374 | -0.482 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -7.65 | 2.84 | 2.02 | 0.374 | -0.482 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.65 | 2.84 | 2.02 | 0.374 | -0.482 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.194 | 0.085 | 0.052 | 0.01 | -0.011 |
Dividends per Share |